The largest database of trusted experimental protocols

Epanova

Manufactured by AstraZeneca

Epanova is a pharmaceutical product manufactured by AstraZeneca. It is a liquid concentrate containing omega-3 carboxylic acids derived from fish oils. The core function of Epanova is to provide a source of omega-3 fatty acids.

Automatically generated - may contain errors

Lab products found in correlation

2 protocols using epanova

1

Dietary Patterns and Statin Intervention

Check if the same lab product or an alternative is used in the 5 most similar protocols
Diets were designed to be isocaloric and reflect typical human Western and heart healthy dietary patterns. The composition and ingredients have been previously described [18 (link)]. Briefly, both diets provided 47% of energy (E) as carbohydrate, 38% E as fat, and 15% E as protein. The diets differed in the types of carbohydrate and fat, quantity of cholesterol and fiber, and fish oil supplementation. The WD was high in refined carbohydrate (sugar, white flour), saturated fat (butter), and cholesterol, whereas the HHD was rich in unrefined carbohydrate (whole wheat flour, oats), unsaturated fat (canola, soybean and corn oils), and fiber (freeze-dried fruits and vegetables mix, Futureceuticals, Momence, IL). HHD-fed pigs also received fish oil supplements (Epanova 1000 mg [550 mg EPA+200 mg DHA as free fatty acids], AstraZeneca, Cambridge, MA) three times per week. Pigs in the atorvastatin (Lipitor, Pfizer, New York, NY) therapy groups received 20 mg/day during months 1–3 and 40 mg/day during the months 4–6 of the intervention to accommodate increases in body weight.
+ Open protocol
+ Expand
2

Dietary Patterns and Statin Intervention

Check if the same lab product or an alternative is used in the 5 most similar protocols
Diets were designed to be isocaloric and reflect typical human Western and heart healthy dietary patterns. The composition and ingredients have been previously described [18 (link)]. Briefly, both diets provided 47% of energy (E) as carbohydrate, 38% E as fat, and 15% E as protein. The diets differed in the types of carbohydrate and fat, quantity of cholesterol and fiber, and fish oil supplementation. The WD was high in refined carbohydrate (sugar, white flour), saturated fat (butter), and cholesterol, whereas the HHD was rich in unrefined carbohydrate (whole wheat flour, oats), unsaturated fat (canola, soybean and corn oils), and fiber (freeze-dried fruits and vegetables mix, Futureceuticals, Momence, IL). HHD-fed pigs also received fish oil supplements (Epanova 1000 mg [550 mg EPA+200 mg DHA as free fatty acids], AstraZeneca, Cambridge, MA) three times per week. Pigs in the atorvastatin (Lipitor, Pfizer, New York, NY) therapy groups received 20 mg/day during months 1–3 and 40 mg/day during the months 4–6 of the intervention to accommodate increases in body weight.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!